Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Invested Capital (2016 - 2025)

Dare Bioscience (DARE) has disclosed Invested Capital for 11 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital rose 429.6% year-over-year to $4.9 million, compared with a TTM value of $4.9 million through Sep 2025, up 429.6%, and an annual FY2024 reading of -$6.0 million, down 19.03% over the prior year.
  • Invested Capital was $4.9 million for Q3 2025 at Dare Bioscience, up from -$10.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $38.8 million in Q4 2021 and bottomed at -$11.0 million in Q1 2024.
  • Average Invested Capital over 5 years is $8.0 million, with a median of $4.3 million recorded in 2021.
  • The sharpest move saw Invested Capital surged 25641.13% in 2021, then crashed 501.92% in 2025.
  • Year by year, Invested Capital stood at $38.8 million in 2021, then tumbled by 71.33% to $11.1 million in 2022, then plummeted by 145.42% to -$5.0 million in 2023, then fell by 19.03% to -$6.0 million in 2024, then soared by 181.44% to $4.9 million in 2025.
  • Business Quant data shows Invested Capital for DARE at $4.9 million in Q3 2025, -$10.7 million in Q2 2025, and -$7.2 million in Q1 2025.